Superior vena cava syndrome secondary to an angiotropic large cell lymphoma
BACKGROUND Angiotropic large cell lymphoma (ALCL) is characterized by the intravascular proliferation of malignant lymphoid cells in small and medium‐sized blood vessels. In the current study, the authors report an unusual case in which the initial presentation of the ALCL was that of superior vena...
Gespeichert in:
Veröffentlicht in: | Cancer 2000-12, Vol.89 (12), p.2515-2520 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUND
Angiotropic large cell lymphoma (ALCL) is characterized by the intravascular proliferation of malignant lymphoid cells in small and medium‐sized blood vessels. In the current study, the authors report an unusual case in which the initial presentation of the ALCL was that of superior vena cava (SVC) syndrome.
METHODS
The case is presented, followed by a general review of the literature regarding ALCL.
RESULTS
Surgical intervention was required for diagnosis in this case. Successful treatment with chemotherapy followed by involved field radiation ensued with a maintained disease remission at 48 months of follow‐up.
CONCLUSIONS
Although usually presenting in small blood vessels, ALCL can present initially with large blood vessel involvement and should be considered in the differential diagnosis of this condition, even in the absence of extravascular lymph node involvement. Aggressive treatment with antineoplastic therapy is warranted and may result in long term recurrence free survival. Cancer 2000;89:2515–20. © 2000 American Cancer Society.
A case of angiotropic large cell lymphoma presenting in large blood vessels as superior vena cava syndrome is presented. The discussion focuses on aspects of a particular predilection for the intravascular space in this unusual presentation. |
---|---|
ISSN: | 0008-543X 1097-0142 |
DOI: | 10.1002/1097-0142(20001215)89:12<2515::AID-CNCR1>3.0.CO;2-H |